[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356057-105":59,"doc-detail-356057-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","an-herbal-formula-sh003-alleviates-colorectal-cancer-through-dual-targeting-of-adaptive-and-innate-checkpoints-pd-l1cd47","An herbal formula, SH003 alleviates colorectal cancer through dual targeting of adaptive and innate checkpoints PD-L1/CD47","","Background Colorectal cancer (CRC) is the third most common cancer, and immunotherapy that simultaneously targets adaptive and innate immune checkpoints can enhance anti-tumor activity. An herbal formula, SH003, shows beneficial effects across multiple cancers, but its anti-CRC efficacy via dual targeting of PD-L1/CD47 has not been fully established. This study evaluates SH003’s effects on CRC growth and immune responses using patient-derived organoids and CRC models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-herbal-formula-sh003-alleviates-colorectal-cancer-through-dual-targeting-of-adaptive-and-innate-checkpoints-pd-l1cd47/356057/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-herbal-formula-sh003-alleviates-colorectal-cancer-through-dual-targeting-of-adaptive-and-innate-checkpoints-pd-l1cd47/356057.png","ImageObject",300,407,{"name":92,"@type":93},"kopisore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research goal of the study?","Question",{"text":112,"@type":113},"To determine whether the herbal formula SH003 alleviates colorectal cancer by dual targeting the adaptive and innate immune checkpoints PD-L1 and CD47.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the effects of SH003 tested on colorectal cancer?",{"text":117,"@type":113},"Using CRC patient-derived organoids and CRC cell lines, with assays including quantitative real-time PCR, Western blot, flow cytometry, immunofluorescence, and evaluations of cytotoxicity, proliferation, and apoptosis. T cell immunity was assessed via co-culture and an in vivo CRC model.",{"name":119,"@type":110,"acceptedAnswer":120},"What key outcomes did SH003 produce in CRC models?",{"text":121,"@type":113},"SH003 reduced CRC growth, decreased ATP and Ki67, suppressed PD-L1 and CD47 expression, and inhibited tumor progression in vivo. It also increased IL-2 production and promoted CD8+ T cell infiltration while reducing PD-L1/CD47 and c-Myc expression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356057,1790588064,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Han et al. Cancer Cell International (2026) 26:282 Cancer Cell International  \n[https://doi.org/10.1186/s12935-026-04338-8](https://doi.org/10.1186/s12935-026-04338-8)  \nRESEARCH Open Access  \nAn herbal formula, SH003 alleviates colorectal   cancer through dual targeting of adaptive and innate checkpoints PD-L1/CD47  \nNa-Ra Han 1,2, Hyun-Ha Hwang3, Tae-Hyoun Kim3, Hyeong-Chan Lee3, Tae-Hoo Yi4, Hi-Joon Park5, Seong-Gyu Ko2,6 and Phil-Dong Moon7*  \nAbstract  \nBackground Colorectal cancer (CRC) is the third most common cancer. The use of immunotherapy for cancer has become widespread in recent decades and adaptive and innate checkpoints can be simultaneously targeted for enhanced immunotherapy. An herbal formula, SH003 has beneficial effects against multiple cancers. However, the anti-CRC efficacy of SH003 through dual targeting of adaptive and innate checkpoints, PD-L1/CD47 remain to be investigated.  \nMethods We used two types of CRC patient-derived organoids (PDOs) and two types of CRC cell lines, and analyzed PD-L1 and CD47 expression levels with quantitative real-time PCR, Western blot, flow cytometry assays, and immunofluorescence staining. The cytotoxicity, proliferation, and apoptosis analysis were applied to clarify the regulatory effects on CRC growth. T cell immunity was analyzed through a co-culture system of CRC cell lines and T cells, as well as in in vivo CRC model.  \nResults SH003 reduced the growth of CRC PDOs, leading to morphological changes and decreases in ATP and Ki67 levels. SH003 inhibited the mRNA and protein expression of both PD-L1 and CD47 though the regulation of c-Myc in CRC PDOs. In addition, SH003 suppressed VEGF, TNF-α, and IL-1β in CRC PDOs. This effect was validated in experiments of CRC cell lines, revealing that SH003 suppressed both PD-L1 and CD47 expression increased by IFN-γ stimulation via the regulation of c-Myc and reduced CRC progression. SH003 also enhanced the T cell-mediated killing of CRC cells with increased IL-2 production. In an in vivo CRC model, SH003 inhibited tumor growth while reducing both PD-L1, CD47, and c-Myc expression and increasing CD8+ T cell infiltration.  \nConclusions Our investigation demonstrated that SH003 served as a novel CRC immunotherapy by the dual targeting of adaptive and innate checkpoints, PD-L1/CD47 via the regulation of c-Myc signaling, highlighting that SH003 may be an effective herbal candidate drug for the treatment of CRC.  \nKeywords SH003, Colorectal cancer, Patient-derived organoids, PD-L1, CD47, Immunotherapy  \n*Correspondence:  \nPhil-Dong Moon [doggy012@hanmail.net](doggy012@hanmail.net)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nHan et al. Cancer Cell International (2026) 26:282  \nBackground  \nIn 2021, colorectal cancer (CRC) was the leading cause of cancer death in both men (3rd) and w","cbCaio4Cz1iN7Dv3","https://ap.wps.com/l/cbCaio4Cz1iN7Dv3","pdf",1930884,12,"English","# Background\n## Methods\n## Results\n## Conclusions\n# Keywords","[{\"question\":\"What is the main research goal of the study?\",\"answer\":\"To determine whether the herbal formula SH003 alleviates colorectal cancer by dual targeting the adaptive and innate immune checkpoints PD-L1 and CD47.\"},{\"question\":\"How were the effects of SH003 tested on colorectal cancer?\",\"answer\":\"Using CRC patient-derived organoids and CRC cell lines, with assays including quantitative real-time PCR, Western blot, flow cytometry, immunofluorescence, and evaluations of cytotoxicity, proliferation, and apoptosis. T cell immunity was assessed via co-culture and an in vivo CRC model.\"},{\"question\":\"What key outcomes did SH003 produce in CRC models?\",\"answer\":\"SH003 reduced CRC growth, decreased ATP and Ki67, suppressed PD-L1 and CD47 expression, and inhibited tumor progression in vivo. It also increased IL-2 production and promoted CD8+ T cell infiltration while reducing PD-L1/CD47 and c-Myc expression.\"}]","An herbal formula, SH003 alleviates colorectal cancer through dual targeting of adaptive and innate checkpoints PD-L1/CD47 | PDF",1790123093,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79406a3bbf89c1084832c9dcdaba7f9d.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a77434feece4f0c2c4546323dc11edd5.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c2c6a076b1944729474df37026f315b.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06d5749195df553379284d6e6522e824.webp",980,1306]